CIPLA
Back to All Ratios
|
CIPLA Last 5 Year PAT Growth History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
PAT Growth(%) | 46.55 | 10.78 | 6.59 | 55.23 | 2.48 |
What is the latest PAT Growth ratio of CIPLA ?
Year | PAT Growth |
---|---|
Mar2024 | 46.55 |
Mar2023 | 10.78 |
Mar2022 | 6.59 |
Mar2021 | 55.23 |
Mar2020 | 2.48 |
How is PAT Growth of CIPLA Trending?
Years | PAT Growth | % Change | |
---|---|---|---|
Mar2024 | 46.55 | 331.82 | |
Mar2023 | 10.78 | 63.58 | |
Mar2022 | 6.59 | -88.07 | |
Mar2021 | 55.23 | 2,127.02 | |
Mar2020 | 2.48 | - |
Other Financial Ratios of CIPLA
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare PAT Growth ratio of peers of CIPLA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CIPLA | ₹125,283.0 Cr | 2.4% | 2.5% | 14% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹432,960.0 Cr | 3.1% | 3.1% | 17.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹165,003.0 Cr | 10.2% | 6.7% | 61.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,508.0 Cr | 2.1% | 2.9% | 31.4% | Stock Analytics | |
MANKIND PHARMA | ₹107,386.0 Cr | 0.8% | 15.9% | 9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,256.0 Cr | 3.2% | 1.3% | -0.2% | Stock Analytics |
CIPLA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | 2.4% |
2.5% |
14% |
SENSEX | 3.6% |
5.8% |
10.1% |
You may also like the below Video Courses